One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Journals package 3months
-
http://medilib.ir
- Duration of Time : 93 Day
- :
Price : 100$- Special Price : 50$
Editorial Board
doi : 10.1016/S0161-6420(24)00373-7
Volume 131, Issue 9, September 2024, Pages A1-A2
Five-Year Clinical Trial of the Low-Concentration Atropine for Myopia Progression (LAMP) Study
Phase 3 Randomized Clinical Trial of the Safety and Efficacy of Travoprost Intraocular Implant in Patients with Open-Angle Glaucoma or Ocular Hypertension
Dexamethasone Intracanalicular Insert for Clinically Significant Aqueous-Deficient Dry Eye
An Evaluation of the Efficacy and Safety of Timolol Maleate 0.5% Microdrops Administered with the Nanodropper
Association between Glucagon-like Peptide-1 Receptor Agonists and the Risk of Glaucoma in Individuals with Type 2 Diabetes
Corneoscleral Melt After Implantation of a Ranibizumab Port Delivery System
The Risk of Optic Neuritis following mRNA Coronavirus Disease 2019 Vaccination Compared to Coronavirus Disease 2019 Infection and Other Vaccinations
Choroid Metastasis of Retroperitoneal Mucinous Cystadenocarcinoma
Assessment of Visual Function with Cotoretigene Toliparvovec in X-Linked Retinitis Pigmentosa in the Randomized XIRIUS Phase 2/3 Study
Delays between Uveal Melanoma Diagnosis and Treatment Increase the Risk of Metastatic Death
Treatment of Noninfectious Uveitic Macular Edema with Periocular and Intraocular Corticosteroid Therapies
Dendritic Corneal Stromal Pigmentation: A Spillover of Nevus of Ota?
Outcomes and Complications of Limbal Stem Cell Allograft Transplantation
Re: Bradley et al.: Comparing the accuracy of peripapillary OCT scans and visual fields to detect glaucoma worsening. (Ophthalmology. 2023;130:631-639)
Re: Sabharwal et al.: Early endophthalmitis incidence and risk factors after glaucoma surgery in the Medicare population from 2016 to 2019(Ophthalmology. 2024;131:179–187)
Re: Stålhammar G: Delays between uveal melanoma diagnosis and treatment increase the risk of metastatic death (Ophthalmology. 2024;131:1094-1104)
